X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3677) 3677
Publication (845) 845
Book Review (23) 23
Book Chapter (15) 15
Conference Proceeding (8) 8
Magazine Article (7) 7
Book / eBook (5) 5
Dissertation (5) 5
Newsletter (4) 4
Data Set (3) 3
Trade Publication Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3475) 3475
index medicus (2593) 2593
hiv infections - drug therapy (2590) 2590
anti-retroviral agents - therapeutic use (2555) 2555
female (2174) 2174
male (2166) 2166
adult (1891) 1891
hiv (1822) 1822
infectious diseases (1421) 1421
middle aged (1309) 1309
antiretroviral therapy (1187) 1187
immunology (995) 995
antiviral agents (959) 959
human immunodeficiency virus--hiv (912) 912
hiv infection (843) 843
aids (748) 748
viral load (735) 735
highly active antiretroviral therapy (705) 705
hiv infections - complications (677) 677
cd4 lymphocyte count (658) 658
drug therapy (616) 616
hiv infections - virology (608) 608
health aspects (606) 606
virology (596) 596
antiretroviral drugs (589) 589
hiv infections - immunology (571) 571
risk factors (571) 571
research (537) 537
young adult (536) 536
anti-retroviral agents - administration & dosage (525) 525
article (513) 513
anti-retroviral agents - adverse effects (511) 511
human-immunodeficiency-virus (505) 505
adolescent (487) 487
hiv infections - epidemiology (484) 484
acquired immune deficiency syndrome--aids (477) 477
treatment outcome (470) 470
therapy (438) 438
aids/hiv (426) 426
hiv patients (414) 414
infection (409) 409
care and treatment (397) 397
human immunodeficiency virus (393) 393
hiv infections - blood (384) 384
analysis (383) 383
research article (381) 381
microbiology (379) 379
mortality (379) 379
prevalence (375) 375
hiv-1 (373) 373
anti-retroviral agents - pharmacology (362) 362
virus diseases (353) 353
aged (349) 349
cohort studies (348) 348
cross-sectional studies (348) 348
active antiretroviral therapy (347) 347
antiretroviral agents (332) 332
medicine (331) 331
infections (314) 314
prospective studies (312) 312
rna, viral - blood (311) 311
prevention (304) 304
medicine, general & internal (303) 303
pharmacology & pharmacy (301) 301
animals (300) 300
public, environmental & occupational health (298) 298
antiretroviral therapy, highly active (297) 297
child (290) 290
pregnancy (286) 286
hiv infections - prevention & control (280) 280
hiv-1 - genetics (274) 274
hiv infections - diagnosis (272) 272
hiv/aids (272) 272
hiv infections - transmission (261) 261
abridged index medicus (260) 260
risk (260) 260
retrospective studies (254) 254
hiv-1 - drug effects (251) 251
dosage and administration (244) 244
acquired immune deficiency syndrome (234) 234
disease progression (231) 231
drug therapy, combination (229) 229
disease (227) 227
infant (227) 227
child, preschool (225) 225
adults (222) 222
infected patients (220) 220
medicine & public health (220) 220
protease inhibitors (216) 216
usage (208) 208
patients (207) 207
time factors (204) 204
viruses (203) 203
science (201) 201
cd4 antigen (199) 199
cd4-positive t-lymphocytes - immunology (198) 198
hiv-1 - isolation & purification (195) 195
multidisciplinary sciences (193) 193
children (191) 191
studies (183) 183
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3642) 3642
French (18) 18
Spanish (14) 14
Russian (7) 7
Portuguese (6) 6
Chinese (5) 5
German (5) 5
Japanese (4) 4
Turkish (2) 2
Czech (1) 1
Dutch (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 02/2015, Volume 372, Issue 6, pp. 509 - 518
Preventing HIV-1 infection is a high global priority. This study assessed prevention strategies in young women in South Africa, Uganda, and Zimbabwe using oral... 
TRIALS | MEDICINE, GENERAL & INTERNAL | TRANSMISSION | ANTIRETROVIRAL PROPHYLAXIS | MICROBICIDE | PREVENTION | ADHERENCE | GEL | HIV Infections - prevention & control | Humans | Middle Aged | Drug Resistance, Viral | Administration, Intravaginal | Deoxycytidine - blood | Adenine - blood | Tenofovir | Young Adult | Adenine - adverse effects | Adult | Deoxycytidine - adverse effects | Female | Organophosphonates - blood | Surveys and Questionnaires | Anti-Retroviral Agents - blood | Drug Therapy, Combination | Emtricitabine | Adenine - analogs & derivatives | HIV Seropositivity | Administration, Oral | HIV-1 - drug effects | Deoxycytidine - administration & dosage | Anti-Retroviral Agents - adverse effects | Organophosphonates - adverse effects | Africa South of the Sahara | Adenine - administration & dosage | Pre-Exposure Prophylaxis | Organophosphonates - administration & dosage | Medication Adherence | Anti-Retroviral Agents - administration & dosage | Adolescent | HIV Infections - complications | Deoxycytidine - analogs & derivatives | Women | Care and treatment | HIV infection in women | Dosage and administration | HIV infection | Health aspects | Risk factors | Intervention | Creatinine | Antiretroviral drugs | Motivation | Human immunodeficiency virus--HIV | Prophylaxis | Vagina | Infections | Preventive medicine
Journal Article
Journal of Pharmaceutical and Biomedical Analysis, ISSN 0731-7085, 05/2017, Volume 138, pp. 223 - 230
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 378, Issue 9787, pp. 279 - 281
Journal Article
Journal Article
AIDS, ISSN 0269-9370, 09/2007, Volume 21, Issue 14, pp. 1899 - 1907
Objectives: To describe first dose and steady state antiretroviral drug exposure in the female genital tract. Design: Non-blinded, single center, open-label... 
Women | Genital tract | HIV | Prophylaxis | Sexual transmission | Pharmacokinetics | Antiretroviral therapy | genital tract | INFECTIOUS DISEASES | sexual transmission | antiretroviral therapy | VALIDATION | PREVENTION | PENETRATION | IMMUNOLOGY | CEREBROSPINAL-FLUID | prophylaxis | PROTEASE INHIBITOR | TRICHOMONAS-VAGINALIS | VIROLOGY | LIQUID-CHROMATOGRAPHY | pharmacokinetics | INFECTION | MACAQUES | TENOFOVIR | women | Lamivudine - administration & dosage | Humans | Deoxycytidine - blood | Zidovudine - administration & dosage | Tenofovir | Deoxycytidine - pharmacokinetics | HIV Protease Inhibitors - pharmacokinetics | Atazanavir Sulfate | Genitalia, Female - metabolism | Emtricitabine | HIV Infections - blood | HIV Protease Inhibitors - blood | Adenine - analogs & derivatives | Pyridines - administration & dosage | Benzoxazines - administration & dosage | Administration, Oral | Anti-Retroviral Agents - pharmacokinetics | Deoxycytidine - administration & dosage | Lopinavir | HIV Protease Inhibitors - administration & dosage | Adenine - pharmacokinetics | Pyrimidinones - blood | Anti-Retroviral Agents - administration & dosage | Oligopeptides - administration & dosage | Pyrimidinones - administration & dosage | Zidovudine - blood | Deoxycytidine - analogs & derivatives | Reverse Transcriptase Inhibitors - blood | Zidovudine - pharmacokinetics | Pyridines - pharmacokinetics | Reverse Transcriptase Inhibitors - administration & dosage | Adenine - blood | Reverse Transcriptase Inhibitors - pharmacokinetics | Benzoxazines - pharmacokinetics | Adult | Benzoxazines - blood | Female | Organophosphonates - blood | Anti-Retroviral Agents - blood | Drug Therapy, Combination | Oligopeptides - blood | Oligopeptides - pharmacokinetics | Lamivudine - blood | Lamivudine - pharmacokinetics | Adenine - administration & dosage | Organophosphonates - pharmacokinetics | Organophosphonates - administration & dosage | Pyridines - blood | Pyrimidinones - pharmacokinetics | HIV Infections - drug therapy
Journal Article
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 01/2019, Volume 63, Issue 1
Journal Article
BMJ Open, ISSN 2044-6055, 09/2017, Volume 7, Issue 9, p. e014679
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 4/2013, Volume 207, Issue 8, pp. 1226 - 1234
Background. Effective antiretroviral therapy (ART) dramatically reduces human immunodeficiency virus (HIV) transmission. However, isolated shedding of HIV type... 
HIV/AIDS | Antiretrovirals | HIV | RNA | Semen | Men | Viruses | Viral load | Blood | HIV 1 | Blood plasma | semen | transmission | viral load | antiretroviral therapy | INFECTIOUS DISEASES | RALTEGRAVIR | BLOOD-PLASMA | MICROBIOLOGY | TREATED PATIENTS | IMMUNOLOGY | HUMAN-IMMUNODEFICIENCY-VIRUS | SEMINAL PLASMA SAMPLES | PROTEASE INHIBITORS | MALE GENITAL-TRACT | HIV-1-INFECTED MEN | INFECTED PATIENTS | HIV-1 - pathogenicity | Prospective Studies | Triazoles - blood | Cyclohexanes - pharmacology | Humans | Molecular Sequence Data | Male | RNA, Viral - blood | Virus Shedding | Case-Control Studies | Viral Load | Incidence | Cyclohexanes - therapeutic use | RNA, Viral - genetics | Time Factors | Base Sequence | Pyrrolidinones - pharmacology | HIV Infections - transmission | Anti-Retroviral Agents - blood | Semen - virology | Raltegravir Potassium | Triazoles - therapeutic use | Amino Acid Sequence | Anti-Retroviral Agents - therapeutic use | Sexual Behavior | HIV Infections - virology | Anti-Retroviral Agents - pharmacology | Pyrrolidinones - therapeutic use | Pyrrolidinones - blood | Treatment Outcome | HIV-1 - genetics | Cyclohexanes - blood | Triazoles - pharmacology | Sequence Analysis, RNA | Viremia - virology | HIV Infections - drug therapy | Antiviral agents | Development and progression | Genetic aspects | Dosage and administration | Research | HIV infection
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 07/2015, Volume 209, pp. 280 - 287
Journal Article